May 13 (Reuters) - Medical device maker Kensey Nash Corp agreed to sell its endovascular business to single-use medical device maker Spectranetics Corp for $24 million, including possible milestone ...
Colorado Springs, Colo.-based Spectranetics Corp., a medical device manufacturer, has agreed to pay the United States $4.9 million in civil damages plus a $100,000 forfeiture to resolve claims that ...
Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease
Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion ...
Royal Phillips NV is set to acquire Spectranetics Corp. for €1.9 billion ($2.2 billion). The proposed acquisition is the latest in a string of efforts the Amsterdam, the Netherlands-based company has ...
John Schulte, the former CEO of Colorado Springs-based medical laser maker Spectranetics Corp., was found guilty of one charge but acquitted of 11 other counts ...
The Dutch healthcare technology company Philips will purchase Colorado Springs, Colo.-based The Spectranetics Corp. for about $2.16 billion, reports Denver Business Journal. Here are four things to ...
The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
A group of California doctors stopped enrolling new patients last week in a clinical trial using Spectranetics Corp. medical lasers after federal regulators raised safety concerns about the lasers, ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in ...
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Excimer laser procedure to be tested on more than 350 patients. COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Spectranetics Corporation (Nasdaq:SPNC - News) today announced that it plans to initiate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results